Senator Sheldon Whitehouse (D-Rhode Island) recently sold shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on October 03rd, the Senator disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on September 4th.
Senator Sheldon Whitehouse also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 9/4/2025.
- Sold $1,001 - $15,000 in shares of Verizon Communications NYSE: VZ on 9/4/2025.
- Sold $15,001 - $50,000 in shares of Honeywell International NASDAQ: HON on 9/4/2025.
- Sold $15,001 - $50,000 in shares of Apple NASDAQ: AAPL on 9/4/2025.
- Sold $15,001 - $50,000 in shares of NVIDIA NASDAQ: NVDA on 9/4/2025.
- Sold $15,001 - $50,000 in shares of Microsoft NASDAQ: MSFT on 9/4/2025.
- Sold $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 8/28/2025.
- Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 8/28/2025.
- Sold $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 8/28/2025.
- Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 8/28/2025.
UnitedHealth Group Price Performance
UnitedHealth Group stock opened at $360.17 on Friday. The company's fifty day moving average price is $307.84 and its 200 day moving average price is $355.58. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.
Analyst Ratings Changes
A number of research analysts have weighed in on the company. Baird R W lowered UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Finally, Barclays raised their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $358.95.
Read Our Latest Report on UnitedHealth Group
Institutional Trading of UnitedHealth Group
Institutional investors and hedge funds have recently bought and sold shares of the stock. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the period. IAG Wealth Partners LLC purchased a new stake in UnitedHealth Group in the 1st quarter valued at about $42,000. LFA Lugano Financial Advisors SA acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $25,000. Finally, O Brien Wealth Partners LLC grew its position in UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after acquiring an additional 37 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
About Senator Whitehouse
Sheldon Whitehouse (Democratic Party) is a member of the U.S. Senate from Rhode Island. He assumed office on January 3, 2007. His current term ends on January 3, 2031.
Whitehouse (Democratic Party) ran for re-election to the U.S. Senate to represent Rhode Island. He won in the general election on November 5, 2024.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
